Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Peking Union Medical College Hospital